Paul Gitman

Paul Gitman appears in our data through filings on Biospecifics Technologies Corp shares, published by SEC (Form 4). Between 23 August 2018 and 2 December 2020, the trades on record add up to 16 filings.

Sales make up the whole of the open-market record (12 sales, €3.1M). Besides market trades, the filings include 2 share grants.

The latest filing, published on 2 December 2020, reports a transaction in Biospecifics Technologies Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.